| Disease Browser
|
Parent Node:
 amyotrophic lateral sclerosis (MONDO:0004976) |
Parent Node:
hereditary motor neuron disease (MONDO:0024257) |
Parent Node:
inherited neurodegenerative disorder (MONDO:0024237) |
..Starting node
.. familial amyotrophic lateral sclerosis ()
|
Child Nodes:
|
| ........amyotrophic lateral sclerosis type 1 () |
| ........amyotrophic lateral sclerosis type 11 () |
| ........amyotrophic lateral sclerosis type 12 () |
| ........amyotrophic lateral sclerosis type 15 () |
| ........amyotrophic lateral sclerosis type 17 () |
| ........amyotrophic lateral sclerosis type 18 () |
| ........amyotrophic lateral sclerosis type 19 () |
| ........amyotrophic lateral sclerosis type 20 () |
| ........amyotrophic lateral sclerosis type 4 () |
| ........amyotrophic lateral sclerosis, susceptibility to, 25 () |
| ........FTDALS () |
| ........juvenile amyotrophic lateral sclerosis () |
| ........spinocerebellar ataxia type 2 () |
Sister Nodes: |
..adult spinal muscular atrophy ()
|
..Alexander disease ()
|
..angioid streaks of choroid ()
|
..attenuated ChC)diak-Higashi syndrome ()
|
..autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures ()
|
..autosomal recessive cerebral atrophy ()
|
..boylan dew greco syndrome ()
|
..Canavan disease ()
|
..Chediak-Higashi syndrome ()
|
..Cockayne syndrome ()
|
..deafness dystonia syndrome ()  L: 00113;
|
..dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities ()
|
..early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome ()
|
..encephalopathy due to beta-mercaptolactate-cysteine disulfiduria ()
|
..facial onset sensory and motor neuronopathy ()
|
..familial amyotrophic lateral sclerosis ()
|
..familial infantile bilateral striatal necrosis () L: 00075;
|
..fatal post-viral neurodegenerative disorder ()
|
..ferro-cerebro-cutaneous syndrome ()
|
..genetic neurodegenerative disease with dementia ()
|
..GM2 gangliosidosis ()
|
..hereditary optic atrophy ()
|
..hereditary spastic paraplegia ()
|
..Huntington disease and related disorders ()
|
..hypotonia-speech impairment-severe cognitive delay syndrome ()
|
..infantile cerebellar-retinal degeneration () L: 00108;
|
..infantile-onset axonal motor and sensory neuropathy-optic atrophy-neurodegenerative syndrome ()
|
..intermediate spinal muscular atrophy ()
|
..ITPA-related encephalopathy ()
|
..juvenile spinal muscular atrophy ()
|
..Krabbe disease ()
|
..lateral sclerosis ()
|
..leukoencephalopathy-metaphyseal chondrodysplasia syndrome ()
|
..microphthalmia-brain atrophy syndrome ()
|
..mitochondrial DNA depletion syndrome 4a () L: 00032;
|
..multiple mitochondrial dysfunctions syndrome 4 () L: 00530;
|
..multiple sclerosis, susceptibility to, 2 ()
|
..multiple sclerosis, susceptibility to, 3 ()
|
..multiple sclerosis, susceptibility to, 4 ()
|
..muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome ()
|
..myoclonic cerebellar dyssynergia ()
|
..neurodegenerative syndrome due to cerebral folate transport deficiency ()
|
..neuronal ceroid lipofuscinosis ()
|
..neuronal intranuclear inclusion disease ()
|
..neuronopathy, distal hereditary motor, type 2A ()
|
..neuronopathy, distal hereditary motor, type 7A ()
|
..Parkinson disease 18, autosomal dominant, susceptibility to ()
|
..Parkinson disease 5, autosomal dominant, susceptibility to ()
|
..PEHO syndrome ()
|
..Pelizaeus-Merzbacher disease ()
|
..posterior cortical atrophy ()
|
..psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome ()
|
..radiation sensitivity/chromosome instability syndrome, autosomal dominant ()
|
..recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome ()
|
..severe neurodegenerative syndrome with lipodystrophy ()
|
..striatonigral degeneration, childhood-onset ()
|
..tuberous sclerosis ()
|
..vitreoretinal degeneration ()
|
..X-linked adrenoleukodystrophy ()
|
..X-linked neurodegenerative syndrome, Bertini type ()
|
..X-linked neurodegenerative syndrome, Hamel type ()
|
MONDO is developed by the Monarch Initiative. Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM,ClinVar, CTD
|
